Article
CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche
1 Jan 2018
Abstract excerpt
Cancer stem cells (CSCs) are an attractive therapeutic target due to their predicted role in both metastasis and chemoresistance. One of the most commonly agreed on markers for ovarian CSCs is the cell surface protein CD133. CD133+ ovarian CSCs have increased tumorigenicity, resistance to chemotherapy, and increased metastasis. Therefore, we were interested in defining how CD133 is regulated and whether it has a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
